You are here: Home » Current Affairs » Coronavirus » News
Business Standard

National coronavirus positivity rate at 5.20%: Health ministry

India has registered a record in the number of Covid-19 cumulative tests

Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

A health official takes a swab sample of a student who returned from Pakistan at a Covid-19 coronavirus testing center in Srinagar
Coronavirus testing | File photo

India has registered a record in the number of COVID-19 cumulative tests, with over 21.15 crore samples tested, the Union Health Ministry said on Monday.

The country's national positivity rate is pegged at 5.20 per cent.

Progressive countrywide expansion in testing infrastructure has played a crucial role in the steep rise of testing numbers, the ministry underlined.

With2393testing labs in the country including1,220 government laboratories and1,173private laboratories, the daily testing capacity has got a substantial boost.

"India's cumulative national positivity rate is presently pegged at5.20 per cent," the ministry said.

A total of 6,20,216tests were conducted ina span of 24 hours.

"The number of beneficiaries being tested per million every day has shown a consistent and progressive increase. India's tests per million stand at 1,53,298.4 as on date," the ministry highlighted.

Till February 22, the COVID-19 vaccination coverage was 1,11,16,854 through 2,32,317 sessions, as per the provisional report. These include 63,97,849 health care workers (HCWs 1st dose), 9,67,852 HCWs (2nd dose) and 37,51,153 frontline workers (FLW 1st dose).

The 2nd dose of COVID-19 vaccination started onFebruary 13 for those beneficiaries who have completed 28 days after receipt of the 1st dose. Vaccination of the FLWs started onFebruary 2.

As on day-37 of the vaccination drive (21st February), 31,681 vaccine doses were given. Out of which, 24,471 beneficiaries were vaccinated across 1,429 sessions for 1st dose (HCWs and FLWs) and 7,210 HCWs received 2nd dose of vaccine.

Out of total 1,11,16,854 vaccine doses, 1,01,49,002 (HCWs and FLWs) received 1st dose of vaccine and total 9,67,852 HCWs received 2nd dose of vaccine, the ministry said.

It said60.17 per centof the total vaccine doses are concentrated in seven states. Karnataka alone accounts for 11.8 per cent (1,14,043 doses).

India's cumulative recoveries surged to1.06 crore (1,06,99,410) andexceed the active cases by 1,05,49,355 (71.3 times), the ministry underscored.

A totalof 9,695 patients have recovered and got discharged in a span of 24 hours.

The ministry said 80.86 per centof the new recovered cases are observed to be concentrated in five states.

Kerala has reported the maximum number of single day recoveries with 4,345 newly recovered cases. A total of 2,417 people recovered in Maharashtra in a span of 24 hours followed by 460 in Tamil Nadu.

The country's total active cases is1,50,055 as on date whichconsists of 1.36 per centof India's total infections.

A total 14,199new daily cases have been recorded in a span of 24 hours.

Seven states and UTs have not reported any new cases in a span of 24 hours. These are Uttarakhand, Ladakh, Meghalaya, Mizoram, Arunachal Pradesh, Daman and Diu and Dadar and Nagar Haveli, Andaman and Nicobar Islands, the ministry said.

It said86.3 per cent of the new cases are from five states.

Maharashtra continues to report the highest daily new cases at 6,971. It is followed by Kerala with 4,070 while Tamil Nadu reported 452 new cases.

Nineteen states and UTs have not reported any COVID-19 deaths in a span of 24 hours. These are Haryana, Andhra Pradesh, J-K, Rajasthan, Odisha, Goa, Chandigarh, Assam, Manipur, Sikkim, Lakshadweep, Tripura, Nagaland, Ladakh, Meghalaya, Mizoram, Arunachal Pradesh, Daman and Diu and Dadar and Nagar Haveli, Andaman and Nicobar Islands.

Besides,83 deaths were reported in a span of 24 hours, the ministry said adding five states account for 78.31 per centof the new deaths. Maharashtra saw the maximum casualties (35). Kerala reported 15 deaths.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, February 22 2021. 15:28 IST